Department of Pharmacology, Physiology, and Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Aging Cell. 2024 Nov;23(11):e14281. doi: 10.1111/acel.14281. Epub 2024 Jul 23.
Over a lifetime, hematopoietic stem and progenitor cells (HSPCs) are forced to repeatedly proliferate to maintain hematopoiesis, increasing their susceptibility to DNA damaging replication stress. However, the proteins that mitigate this stress, protect HSPC replication, and prevent aging-driven dysregulation are unknown. We report two evolutionarily conserved, ubiquitously expressed chromatin remodeling enzymes with similar DNA replication fork reversal biochemical functions, Zranb3 and Smarcal1, have surprisingly specialized roles in distinct HSPC populations. While both proteins actively mitigate replication stress and prevent DNA damage and breaks during lifelong hematopoiesis, the loss of either resulted in distinct biochemical and biological consequences. Notably, defective long-term HSC function, revealed with bone marrow transplantation, caused hematopoiesis abnormalities in young mice lacking Zranb3. Aging significantly worsened these hematopoiesis defects in Zranb3-deficient mice, including accelerating the onset of myeloid-biased hematopoietic dysregulation to early in life. Such Zranb3-deficient HSPC abnormalities with age were driven by accumulated DNA damage and replication stress. Conversely, Smarcal1 loss primarily negatively affected progenitor cell functions that were exacerbated with aging, resulting in a lymphoid bias. Simultaneous loss of both Zranb3 and Smarcal1 compounded HSPC defects. Additionally, HSPC DNA replication fork dynamics had unanticipated HSPC type and age plasticity that depended on the stress and Zranb3 and/or Smarcal1. Our data reveal both Zranb3 and Smarcal1 have essential HSPC cell intrinsic functions in lifelong hematopoiesis that protect HSPCs from replication stress and DNA damage in unexpected, unique ways.
在一生中,造血干细胞和祖细胞 (HSPC) 被迫反复增殖以维持造血,从而增加了它们对 DNA 损伤复制应激的敏感性。然而,减轻这种应激、保护 HSPC 复制和防止衰老驱动的失调的蛋白质尚不清楚。我们报告了两种进化上保守的、广泛表达的染色质重塑酶,它们具有相似的 DNA 复制叉逆转生化功能,Zranb3 和 Smarcal1,在不同的 HSPC 群体中具有惊人的特殊作用。虽然这两种蛋白质都能积极减轻复制应激并防止终身造血过程中的 DNA 损伤和断裂,但它们的缺失会导致截然不同的生化和生物学后果。值得注意的是,长期 HSC 功能的缺陷,通过骨髓移植揭示,导致缺乏 Zranb3 的年轻小鼠出现造血异常。衰老显著恶化了 Zranb3 缺陷小鼠的这些造血缺陷,包括加速骨髓偏向性造血失调的发生早至生命早期。这种随着年龄增长的 Zranb3 缺陷 HSPC 异常是由积累的 DNA 损伤和复制应激驱动的。相反,Smarcal1 的缺失主要影响祖细胞功能,随着衰老而加剧,导致淋巴样偏向。Zranb3 和 Smarcal1 的同时缺失加剧了 HSPC 缺陷。此外,HSPC DNA 复制叉动力学具有出人意料的 HSPC 类型和年龄可塑性,这取决于应激和 Zranb3 和/或 Smarcal1。我们的数据揭示了 Zranb3 和 Smarcal1 在终身造血中具有 HSPC 细胞内在的基本功能,以出人意料的独特方式保护 HSPC 免受复制应激和 DNA 损伤。